Transparency Market Research

TMR is a market intelligence company providing global business research reports and consulting services.

LTE Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

 

f:id:tmrreport:20130415163903j:plain

According to a new market report published by Transparency Market Research "Global LTE (LTE-FDD, TD-LTE and LTE Advanced) Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" the global LTE market is expected to reach a value of USD 610.71 billion by 2019, growing at a CAGR of 78.6% from 2013 to 2019. Increased need for higher data rates and greater spectral efficiency driven by increased data usage, rapid deployments of smart devices and need for high quality of services on move are some important reasons driving the growth of LTE market globally. This trend is further enhanced by increased adoption of public safety LTE and planned large-scale adoption of LTE by operators in Asia Pacific.

North America was the largest market in terms of revenue generation in 2012 and accounted for 51.3% share of the total LTE market. Asia Pacific is expected grow at a CAGR of 88.7% during the forecast period and register a market size of USD 244.29 billion by 2019. Growth of LTE services in Asia Pacific is mainly spurred by rising LTE infrastructure in China and India.

Worldwide LTE infrastructure market is expected to grow at a CAGR of 61.6% during the forecast period. Increased spending by network operators for LTE infrastructure fuelled by increased demand for high-speed and spectrally efficient wireless networks is driving the LTE infrastructure market, globally. LTE-FDD (Long Term Evolution Frequency Division Duplex) held 56.8% share in 2012. With planned launch of LTE Advanced by several operators during the forecast period, the market for LTE Advanced is expected to grow at a CAGR of 175.0% from 2013 to 2019.

The Voice over LTE market is expected to grow at a CAGR of 123.5% during the forecast period. Growth in VoLTE is fuelled by increased demand for voice and messaging services over LTE networks and operators realizing that standalone data networks are not sufficient in meeting customer expectations.

In terms of geography, North America represented the largest market for LTE and was valued at USD 5.36 billion in 2012. The growing adoption of LTE in North America was mainly spurred by the decreasing prices of LTE in comparison to 3G network. However, Asia Pacific is expected to surpass North America by 2015, owing to growing demand for high-speed wireless data and increased spending on infrastructure by operators in this region, especially, China, India, South Korea and Japan.

Among network operators (carriers), Verizon Wireless led the LTE market with a market share of 58.1% in 2012 followed by NTT DoCoMo. Other important network operators include AT&T Mobility, China Mobile, Sprint Corp, T-Mobile, Vodafone and SK Telecom. Among LTE network infrastructure vendors, Ericsson lead the LTE market with a market share of 30.0% in 2012 followed by Huawei.

The global LTE market is segmented as below:

LTE Market Segmentation

By technology

  •     LTE-FDD
  •     TD-LTE
  •     LTE Advanced

By Component

  •     Infrastructure
  •     Chipsets
  •     Terminal equipments (Module, Phone, Router, Tablet and USB Modem)
  •     Network service providers
  •     LTE testing equipments

By Service and Application

  • Mobile cloud services
  • M2M and Connected Devices
  • P2P messaging
  • Browsing
  • Public Safety LTE
  • Games
  • TV/Video-on-Demand
  • Music
  • M-commerce
  • VoLTE

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Browse more market research reports: Transparency Market Research

 

Nanomedicine Market is Expected to Reach USD 177.60 Billion Globally in 2019: Transparency Market Research

f:id:tmrreport:20140224202942j:plain

Transparency Market Research is Published new Market Report "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019," .The market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.

 

The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.

The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.

However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.

North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.

Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.

The global nanomedicine market is categorized into the following segments:

Nanomedicine Market by Application

·         Neurology

·         Cardiovascular

·         Anti-Inflammatory

·         Anti-Infectives

·         Oncology

·         Others

Nanomedicine Market by Geography

·         North America

·         Europe

·         Asia-Pacific

 

·         Rest of the World (RoW)

 

Browse more market research reports: Transparency Market Research

Global Caprolactam Market is Expected to Reach USD 13.80 Billion by 2019: Transparency Market Research

Transparency Market Research has released a new market report titled "Caprolactam (Nylon 6 Fiber and Nylon 6 Resin) Market For Textiles, Carpets, Industrial Yarns, Engineering Plastics, Packaging, Electronics and Other Applications - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019," which observes that the caprolactam demand in 2012 was worth USD 8.66 billion and is expected to reach USD 13.80 billion by 2019, growing at a CAGR of 6.9% from 2013 to 2019. In terms of volume, the demand for caprolactam was 3,580.0 kilo tons in 2012.

Browse the full Report with TOC:http://www.transparencymarketresearch.com/caprolactam-market.html

Caprolactam is an important polymer having host of applications across different industries. Caprolactam is the key raw material for nylon 6. Caprolactam is used to produce nylon 6 fibers and resins that are used extensively in various applications. The growing demand of nylon 6 in engineering and automobile applications as well as rapid economic growth in Asia Pacific is expected to remain the major driving force for the caprolactam market. Volatile raw material prices are expected to be a key challenge for market participants.

Nylon 6 fibers dominated the consumption of caprolactam and accounted for over 66% of total demand in 2012. Superior chemical as well as physical characteristics such as light weight and high tensile strength, nylon 6 fibers have become materials of choice in various textile and carpets application. The use of caprolactam in nylon 6 resin production employed in engineering plastics and electronic applications is anticipated to be the major growth market over the next few years. Similar surge in demand is expected to be witnessed from industrial yarn applications where nylon 6 fibers are used as tire cords for enhanced wear resistance and high strength characteristics.

Asia Pacific accounted for about 51% of the total caprolactam market in 2012, followed by Europe and North America. Asia Pacific is also expected to be the fastest growing regional market in terms of both caprolactam consumption and production. This can be attributed to the growing economies in this region. Skilled labor, cheap availability of raw materials, equipments, and land has resulted in Asia Pacific emerging as a key destination for caprolactam producers. Recently various manufacturers have concentrated on capacity expansion in Asia Pacific to increase their production capacities. Europe is the other major region where caprolactam consumption was very strong and is expected to grow in demand with a CAGR of about 6.4% in terms of volume from 2013 and 2019.

DSM, BASF SE, Honeywell, Ube Industries and Capro Corporation are some of the major participants in the caprolactam industry.

Caprolactam Market - Product Segment Analysis

·         Nylon 6 fiber

·         Nylon 6 resin

Caprolactam Market - Application Segment Analysis

·         Nylon 6 fiber

·         Textiles

·         Carpet

·         Industrial yarns

·         Others (fishing lines, fishing nets, bristles, surgical suture, etc.)

·         Nylon 6 resin

·         Engineering plastic

·         Packaging

·         Electronics

·         Others (musical strings, composites, lysine synthesis, etc.)

Caprolactam Market - Regional Analysis

·         North America

·         Europe

·         Asia Pacific

·         Rest of the World (RoW)

      Browse more market research reports: Transparency Market Research